In today's fast-paced world, maintaining muscle health has become a priority not just for athletes but also for working professionals, teenagers, and individuals using GLP-1 medications for weight management.

In the evolving landscape of gut health, postbiotics are emerging as groundbreaking solutions. Among these, Totipro® stands out as a clinically proven, patented, and award-winning postbiotic, offering significant advancements in gut and overall health.

In the pharmaceutical industry, the quality and reliability of excipients are paramount. galenIQ™ 981 (Isomalt Ph.Eur., USP-NF, JP) is one such excipient, recognized for its consistent performance and compliance with multiple international pharmacopoeial standards.

A notable development in pharmaceutical coating technology is DRUGCOAT NE 30D. It is designed as an aqueous dispersion of a copolymer of methylacrylate and ethyl acrylate that complies with the strict USP/NF guidelines for "Ethyl Acrylate and Methyl Methacrylate Copolymer Dispersion."

As the winter season approaches, personal care routines take center stage, focusing on hydration, soothing, and protection from the harsh cold.

In the pharmaceutical industry, the quest for efficient drug delivery, enhanced solubility, and stabilization of active ingredients is constant. Wacker Chemie AG offers a cutting-edge solution with CAVAMAX® W6 PHARMA, a pharmaceutical-grade alpha-cyclodextrin.

Pycnogenol® is a distinguished nutraceutical ingredient derived from the bark of the French maritime pine tree (Pinus pinaster). Known for its exceptional antioxidant properties, Pycnogenol® is celebrated for its blend of active compounds, including procyanidins, bioflavonoids, and organic acids.

Texture plays a fundamental role in cosmetics formulations not only for product performance, but for user experience as well. The consistency of a product impacts not only how it applies to the skin or hair but also its stability, spread ability, and overall effectiveness.

DKSH has signed a strategic partnership agreement with Trautec, a leader in revolutionary recombinant human collagen technology for skincare and haircare, in Canada and the USA. By distributing Trautec’s ingredients for the personal care industry, DKSH will boost business opportunities for the partnership in Canada and the USA.